IP disputes can have a direct impact on patients. Delays in the development and commercialization of new treatments due to IP litigation can result in fewer available options for patients. Additionally, the cost of litigation can drive up the price of new therapies, making them less accessible. Therefore, resolving IP disputes efficiently is critical to ensuring that patients benefit from the latest advancements in cancer treatment.
